We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$2.97B
AUM Growth
+$174M
Cap. Flow
+$25.7M
Cap. Flow %
0.86%
Top 10 Hldgs %
21.49%
Holding
341
New
21
Increased
129
Reduced
124
Closed
6

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$5.26M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$5.07M
3
IRM icon
Iron Mountain
IRM
+$3.72M
4
MTD icon
Mettler-Toledo International
MTD
+$2.34M
5
DNB
Dun & Bradstreet
DNB
+$2.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.78M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.53M
3
EWY icon
iShares MSCI South Korea ETF
EWY
+$2.27M
4
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$1.8M
5
EMR icon
Emerson Electric
EMR
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 16.25%
2 Technology 14.9%
3 Industrials 14.15%
4 Financials 9.71%
5 Energy 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYX icon
26
Paychex
PAYX
$41.6B
$36.5M 1.23%
898,289
-19,042
-2% -$752K
CVX icon
27
Chevron
CVX
$392B
$35.8M 1.21%
294,819
-1,876
-0.6% -$231K
HD icon
28
Home Depot
HD
$331B
$34.4M 1.16%
454,080
-1,336
-0.3% -$103K
WFC icon
29
Wells Fargo
WFC
$261B
$34.3M 1.15%
829,736
+13,905
+2% +$594K
IRM icon
30
Iron Mountain
IRM
$36.4B
$33.6M 1.13%
1,344,670
+146,327
+12% +$3.72M
MSFT icon
31
Microsoft
MSFT
$3.45T
$33.5M 1.13%
1,007,195
+3,081
+0.3% +$101K
PFE icon
32
Pfizer
PFE
$143B
$32.8M 1.1%
1,204,416
+1,305
+0.1% +$35.5K
STT icon
33
State Street
STT
$50.6B
$31.2M 1.05%
474,400
+448
+0.1% +$30.7K
EMR icon
34
Emerson Electric
EMR
$83.9B
$30.2M 1.02%
466,962
-16,604
-3% -$1.02M
MRK icon
35
Merck
MRK
$322B
$30M 1.01%
659,543
-849
-0.1% -$38.8K
V icon
36
Visa
V
$684B
$29.8M 1%
623,228
+10,612
+2% +$490K
BIV icon
37
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$29.6M 1%
354,335
-7,224
-2% -$599K
CVE icon
38
Cenovus Energy
CVE
$55.7B
$29.2M 0.98%
979,569
-2,000
-0.2% -$59.1K
TD icon
39
Toronto Dominion Bank
TD
$198B
$28.6M 0.96%
636,164
-1,656
-0.3% -$70.4K
ABBV icon
40
AbbVie
ABBV
$443B
$26.1M 0.88%
584,129
-13,247
-2% -$587K
JPM icon
41
JPMorgan Chase
JPM
$935B
$25.8M 0.87%
499,355
+9,064
+2% +$486K
TRMB icon
42
Trimble
TRMB
$13.2B
$25.5M 0.86%
857,852
+28,338
+3% +$775K
GSK icon
43
GSK
GSK
$104B
$25.1M 0.85%
400,657
-1,749
-0.4% -$113K
GOOG icon
44
Alphabet (Google) Class C
GOOG
$4.36T
$24M 0.81%
1,099,265
+24,291
+2% +$537K
LQD icon
45
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$23.6M 0.79%
207,902
-3,586
-2% -$406K
APA icon
46
APA Corp
APA
$13.2B
$22.7M 0.77%
267,174
+2,640
+1% +$219K
CVS icon
47
CVS Health
CVS
$133B
$21.9M 0.74%
385,337
+9,871
+3% +$588K
DOV icon
48
Dover
DOV
$27.6B
$21.6M 0.73%
358,500
+354
+0.1% +$20.4K
NE
49
DELISTED
Noble Corporation
NE
$21.6M 0.73%
653,060
+26,253
+4% +$892K
IGSB icon
50
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$21.5M 0.72%
407,700
-34,256
-8% -$1.8M
1
2
3 4 5

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q3 2013 Portfolio in Review

As of Q3 2013, Welch & Forbes held 341 positions worth $2.97B, up 6.2% from $2.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Welch & Forbes's Q3 2013 filing shows 21 new, 129 increased, 124 reduced and 6 closed positions. Its largest new stake was Edwards Lifesciences: 450,012 shares worth $5.22M. The largest sale was ExxonMobil, an estimated $2.78M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Welch & Forbes's largest Q3 2013 buy was Edwards Lifesciences: 450,012 shares worth $5.22M.
  • Welch & Forbes added most to Invesco Senior Loan ETF in Q3 2013, an estimated $5.07M increase.
  • Welch & Forbes's biggest Q3 2013 reduction was ExxonMobil, cutting an estimated $2.78M.
  • Welch & Forbes fully exited Aberdeen India Fund in Q3 2013, selling an estimated $339K.
  • Welch & Forbes's ten largest holdings make up 21% of its $2.97B portfolio in Q3 2013.
  • Welch & Forbes opened 21 new positions and closed 6 in Q3 2013.
  • Welch & Forbes's portfolio value rose 6.2% quarter-over-quarter to $2.97B.

Based on Welch & Forbes's 13F filing for Q3 2013, filed 31 Oct 2013.